Skip to main content
SpringerLink
Log in

PARTNER 2: Transfemorale TAVI bei Patienten mit intermediärem Risiko überlegen

PARTNER 2: transfemoral TAVI is superior in intermediate risk patients

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Leon MB, Smith CR, Mack MJ, PARTNER 2 Investigators et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. doi:10.1056/NEJMoa1514616

    Google Scholar 

  2. Thourani VH, Kodali S, Makkar RR et al (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. doi:10.1016/S0140-6736(16)30073-3

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardioangiologisches Centrum Bethanien (CCB), Im Prüfling 23, 60389, Frankfurt am Main, Deutschland

    H. Eggebrecht

Authors
  1. H. Eggebrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Eggebrecht.

Ethics declarations

Interessenkonflikt

H. Eggebrecht gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eggebrecht, H. PARTNER 2: Transfemorale TAVI bei Patienten mit intermediärem Risiko überlegen. Kardiologe 10, 208–210 (2016). https://doi.org/10.1007/s12181-016-0075-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-016-0075-3

Search

Navigation